From ‘magic tea’ to dietary drugs, can Besunyen reclaim its glory days?
Once a household name known for its ‘slimming tea,’ the company is looking for a new formula in dietary drugs after years of losses and asset sales Key Takeaways: Besunyen…
0926.HK
Recent Articles
RELATED ARTICLES
- Its Hong Kong listing advancing, will investors drink up Bama Tea shares?
- Forget the pearls and cheese, Chagee says, offering up simpler milk teas for U.S. investors
-
Earnings blow for CSPC Pharma as the state drives a hard bargain
1093.HK
-
Yan Palace flies back to profit growth as revenue sags
1497.HK
-
Feihe’s sliding profits point to China dairy market past its sell-by date
6186.HK
-
NEWS WRAP: Green Tea Group slumps on Hong Kong trading debut
6831.HK
-
BRIEF: Intercont shares fall in first two trading days after U.S. IPO
NCT.US
Discover hidden China stock gems in our weekly newsletter